Skip to main content
. 2016 Mar 5;71(6):1697–1706. doi: 10.1093/jac/dkw025

Table 2.

Patterns of systemic antibiotic use among 762 hospitalized patients, Uganda, 2014

Oral Intravenous/ intramuscular No. of patients Patterns of systemic antibiotic use
DDDs % DDDs DDDs/1000 patient-days DDDs/100 admissions
Antibiotic name
 cephalosporins J01D 5 398 403 409.5 21 109.5 53.7
 combinations of sulphonamides with trimethoprim J01EE 162 0 162 358.0 18 95.7 47.0
 fluoroquinolones J01MA 33 99 132 342.9 17 91.7 45.0
 imidazole derivatives J01XDa 60 188 248 311.4 16 83.3 40.9
 macrolides, lincosamides and streptogramins J01F 56 1 57 248.5 13 66.5 32.6
 penicillins J01C 84 28 112 227.4 11 60.8 29.8
 antimycobacterials J04B 5 0 5 56.0 3 15.0 7.3
 aminoglycosides J01G 0 11 11 15.0 1 4.0 2.0
 tetracyclines J01A 5 0 5 16.0 1 4.3 2.1
 carbapenems J01DH 0 1 1 0.3 0 0.1 0.0
 total 1985.0 530.9 260.5
Route of antibiotic administration
 oral 112 1024.8 52 274.1 134.5
 parenteral (intravenous/intramuscular) 491 960.2 48 256.8 126.0
 total 603 1985.0 100 530.9 260.5

aParenteral formulations of nitroimidazoles are classified as J01XD and oral formulations as P01AB in the WHO ATC/DDD index.